Article
Gilead scraps late-stage trial of blood cancer treatment
Rating:
0.0
Views:
39
Likes:
1
Library:
1
Gilead Sciences Inc said on Friday it was stopping a late-stage trial of its blood cancer combination treatment following an analysis that showed it would not be effective.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value